On May 25, 2022, Pfizer and BioNTech announced topline safety, immunogenicity and vaccine efficacy data from a Phase…
On May 25, 2022, Novavax announced it was participating in a stage of the COVID-19 Vaccine Schedule Combinations…
On May 24, 2022, scientists at the Broad Institute of MIT and Harvard and the University of Massachusetts…
On May 20, 2022, Novavax announced the submission of a request to the European Medicines Agency to expand…
On May 19, 2022, the U.S. National Institutes of Health (NIH) announced that people who reported in a…
On May 19, 2022, WHO issued an emergency use listing (EUL) for CONVIDECIA, a vaccine manufactured by CanSino…
On May 18, 2022, the U.S. National Institutes of Health announced it had awarded approximately $577 million to…
On May 18, 2022, LabCorp announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and…
On May 17, 2022, OraSure Technologies announced that its InteliSwabﾮ COVID-19 rapid tests detect the Omicron BA.2, BA.2.12.1,…
On May 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration expanded emergency use authorization…
On May 16, 2022, working with state and federal wildlife agencies and private and public zoos across Arizona,…
On May 13, 2022, Novavax announced the submission of a request for emergency use authorization to Taiwanﾒs Food…
On May 12, 2022, WHOﾒs COVID-19 Technology Access Pool and the Medicines Patent Pool finalized a licensing agreement…
On May 12, 2022, Cepheid announced it had received Emergency Use Authorization from the U.S. Food & Drug…
On May 12, 2022, the U.S. National Institutes of Health announced that it had licensed 11 COVID-19 research…
On May 11, 2022, Lucira Health announced that it had submitted a request to the U.S. Food and…
On May 11, 2022, Kaiser Permanente Washington Health Research Institute reported that new treatments for people at high…
On May 9, 2022, Lucira Health announced that both its COVID-19 & Flu and COVID-19 molecular tests have…
On May 6, 2022, Novavax announced the submission of variations to the Australian Therapeutic Goods Agency (TGA) and…
On May 6, 2022, Novavax announced that deliveries of it’s COVID-19 vaccine continued around the world and the…
On May 5, 2022, the World Health Organization (WHO) reported estimates that show the full death toll associated…
On May 2, 2022, Sorrento announced its Phase I study of intranasal STI-9199 (COVISHIELDTM) had been fully enrolled…
On Apr. 29, 2022, Moderna announced that it had submitted for a variation to the conditional marketing authorization…
On Apr. 28, 2022, Moderna announced that it had submitted a request for emergency use authorization (EUA) for…
On Apr. 26, 2022, Pfizer and BioNTech submitted an application to the U.S. Food and Drug Administration (FDA)…
On Apr. 25, 2022, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…
On Apr. 22, 2022, Novavax announced initial results from the Phase 1/2 clinical trial of its COVID-Influenza Combination…
On Apr. 22, 2022, the WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name…
On Apr. 21, 2022, Cocrystal Pharma announced a Non-Clinical Evaluation Agreement with the National Institute of Allergy and…
On Apr. 21, 2022, CureVac announced preclinical data demonstrating immune responses and protective efficacy of a bivalent second-generation…